Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

ImaRx reports discoveries related to gene expression enhancement

March 10, 1997

Incyte's LifeSeq database licensed to another top pharmaceutical company

March 7, 1997

MorphoSys/P&U drug and target discovery collaboration

March 6, 1997

Cell Genesys licenses gene activation technology

March 6, 1997

Protein Design Labs grants license to Biogen for humanized antibodies

March 5, 1997

GenPharm and Centocor to codevelop human antibodies

March 5, 1997

Vyrex and SeqWright collaborate to develop CD-Tagging technology

March 4, 1997

Incyte and OncorMed to collaborate on clinical genomics

March 3, 1997

Phogen formed to investigate new drug delivery concept

March 3, 1997

Lilly and Emisphere sign agreement

Feb. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...